Compared with the single drug group, the combination group had a stronger inhibitory effect on cell proliferation in SCLC, indicating that the combination of ATO and APA could synergistically inhibit the proliferation of SCLC cells, while reducing the dose of the combination drug (Fig. 1a, c). Here, ENPEP is linked to small cell lung carcinoma.